This year’s World Ovarian Cancer Day campaign was taken to the next level with huge co-ordination amongst the members of the Irish Network for Gynaecological Oncology and the use of a professional marketing/public relations agency. The aim was to reach a broader audience and to start a conversation amongst women of all ages about signs […]
As World Ovarian Cancer Day approaches, we will be sharing more content about ovarian cancer signs and symptoms; about advances in medical treatments for patients and about positive stories from ovarian cancer survivors. We have been working hard with the very active ovarian cancer community in Ireland over the past few months – patient groups, […]
It’s been a strange end to the year – from one World Ovarian Cancer Day to another. We are focusing on marking WOCD 2020 safely online and highlighting the need for all women to take heed of any signs or symptoms of ovarian cancer even as their healthcare routine is disrupted by COVID-19. It’s still […]
Funding groundbreaking research on ovarian/uterine cancer, its causes and treatments has been a huge focus of the Emer Casey Foundation’s mission. IRELAND In this recent article, Gasch et al 2017 CSC Review, Claudia Gasch, Brendan Ffrench, John O’Leary and Michael F. Gallagher explore the importance of understanding cancer stem cell hierarchies and chemoresistance in ovarian cancer. […]
The research that has been supported by the Emer Casey foundation has focussed on the two main clinical challenges that ovarian cancer presents. The first is that an accurate diagnostic test is not currently available. The second challenge relates to the development of resistance to chemotherapy. Diagnostic test for ovarian cancer Auto-antibody profiling: This was […]
A kConFab, VBCRC research update for the Emer Casey Foundation 2014 By Associate Professor Ian Campbell and Heather Thorne OAM. Since 1997, kConFab has recruited 1600 families Australia wide that are at high risk for the development of breast and/or ovarian cancer. On average each of these families has 4 breast and/or ovarian cancers that […]